Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099344 · ClinicalTrials.gov registry record · Phase 4
Artegraft Versus Propaten Dialysis Grafts
A Phase 4 study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT02099344 is a Phase 4 study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 1 participants.
The verdict
NCT02099344, a Phase 4 study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Compare Artegraft and Propaten grafts for use in dialysis access to see if one performs better than the other. How long each one lasts until a complication arises or until the graft is no longer used will be compared. The study hypothesis is that the Artegraft, being an actual blood vessel, will work better than the manufactured Propaten graft.
Interventions
- DEVICE Artegraft
- DEVICE Propaten
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02099344
The ClinicalTrials.gov registry entry for NCT02099344 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Artegraft is the first listed.
NCT02099344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02099344 about?
NCT02099344 is a clinical study titled "Artegraft Versus Propaten Dialysis Grafts". Compare Artegraft and Propaten grafts for use in dialysis access to see if one performs better than the other. How long each one lasts until a complication arises or until the graft is no longer used will be compared. The study hypothesis is that the Artegraft, being an actual blood vessel, will wo...
What is the current status of trial NCT02099344?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2014-04. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02099344?
The interventions under investigation include: Artegraft (DEVICE), Propaten (DEVICE).
Who is sponsoring clinical trial NCT02099344?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.